Myo-inositol: micronutrient for “fine tuning” of the female reproductive sphere

Myo-inositol is necessary for the synthesis of signal molecules of inositol phosphates involved in effect mediation of reproductive hormones. Insufficiency of myo-inositol is associated with menstrual irregularities, infertility, polycystic ovaries and congenital malformations of the fetus. Myo-inositol supplement improves the formation of ovulatory cycles, mature oocytes, the probability of pregnancy; reduce the risk of folate-resistant malformations, gestational diabetes, and fetal macrosomia. Myo-inositol favorably affects the lipid profile of the blood; prevents excessive weight gain during pregnancy, counteracts the formation of glucose tolerance and insulin resistance in women with menstrual irregularities, reduces chronic inflammation in the atherogenic profile of the blood. Myo-inositol supports antitumor immunity. The level of myo-inositol in the body decreases with the use of nephrotoxic medicinal products. Myo-inositol dependence increases with kidney pathology (pyelonephritis, glomerulonephritis, diabetic nephropathy, nephropathy of pregnancy, renal form of hypertension, etc.), with hyperglycaemic type of nutrition.

[1]  Геннадий Айзикович Новик,et al.  Лечение девушек-подростков с синдромом поликистозных яичников и инсулинорезистентностью , 2018 .

[2]  A. S. Mikhaylyukova,et al.  Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization , 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[3]  Yulong Zhang,et al.  Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET , 2017, Medicine.

[4]  P. Regidor,et al.  Prospective Randomized Study on the Influence of Myoinositol in PCOS Women Undergoing IVF in the Improvement of Oocyte Quality, Fertilization Rate, and Embryo Quality , 2016, International journal of endocrinology.

[5]  Екатерина Евгеньевна Ильюшина.  Отношение к беременности женщин, прибегнувших к экстракорпоральному оплодотворению , 2016 .

[6]  Хуберт Е. Блюм.  Современные проблемы и достижения фундаментальной и клинической медицины , 2015 .

[7]  Ольга Алексеевна Громова,et al.  Систематический анализ фундаментальных и клинических исследований как обоснование необходимости совместного использования эстрогенсодержащих препаратов с препаратами магния и пиридоксина , 2016 .

[8]  Светлана Андреевна Денисенко,et al.  Функциональная биохиия системы мать-плацента-плод , 2013 .

[9]  V. Raparelli,et al.  Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study , 2012, Reproductive Biology and Endocrinology.

[10]  G. Tonni,et al.  Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy. , 2011, Birth defects research. Part A, Clinical and molecular teratology.

[11]  V. Unfer,et al.  Inositol safety: clinical evidences. , 2011, European review for medical and pharmacological sciences.

[12]  K. Mikoshiba,et al.  Inositol 1,4,5-trisphosphate receptors are essential for the development of the second heart field. , 2011, Journal of molecular and cellular cardiology.

[13]  T. Nägele,et al.  Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features , 2011, Journal of Medical Genetics.

[14]  K. Linask,et al.  Fetal alcohol syndrome: cardiac birth defects in mice and prevention with folate. , 2010, American journal of obstetrics and gynecology.

[15]  S. Lam,et al.  The Chemopreventive Agent Myoinositol Inhibits Akt and Extracellular Signal-Regulated Kinase in Bronchial Lesions from Heavy Smokers , 2009, Cancer Prevention Research.

[16]  N. Greene,et al.  Mouse models of neural tube defects: Investigating preventive mechanisms , 2005, American journal of medical genetics. Part C, Seminars in medical genetics.

[17]  R. Steegers-Theunissen,et al.  Involvement of inositol in reproduction. , 2002, Nutrition reviews.

[18]  N. Greene,et al.  Neural tube defects : Prevention by folic acid and other vitamins , 2000, Indian journal of pediatrics.

[19]  J. Madsen,et al.  Pathophysiology, prevention, and potential treatment of neural tube defects. , 2000, Mental Retardation and Developmental Disabilities Research Reviews.

[20]  E. Reece,et al.  Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. , 1998, Teratology.

[21]  E. Reece,et al.  Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats. , 1997, American journal of obstetrics and gynecology.

[22]  N. Greene,et al.  Inositol prevents folate-resistant neural tube defects in the mouse , 1997, Nature Medicine.

[23]  M. Seller.  Vitamins, folic acid and the cause and prevention of neural tube defects. , 2007, Ciba Foundation symposium.

[24]  H. Bank,et al.  Myo‐inositol clearance in renal failure and in patients with normal kidney function , 1977, The American journal of the medical sciences.